Protein Search

Taxonomy

• Homo sapiens (Human)

Protein

• 2-hydroxyacylsphingosine 1-beta-galactosyltransferase / Homo sapiens    Q16880

Source

• Mammary Gland (UBERON_0001911)  

Reported structure

Composition

• Hex:7 HexNAc:2 (avg mass : 1559.4021 )
• Hex:5 HexNAc:2 dHex:1 (avg mass : 1381.2603 )
• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )
• Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
• Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
• Hex:9 HexNAc:2 (avg mass : 1883.6869 )
• Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )

Disease

• Cancer, breast (DOID:1612)

Reference

• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed

Reported glycosite

• 2-hydroxyacylsphingosine 1-beta-galactosyltransferase / Homo sapiens :
  •        Asn-78
  •        Asn-333
  •        Asn-442

Mass spectrometry validated peptide

• YPGIFNSTTSDAFIQSK (17aa)
  •    Q16880    Asn-78
• GIFNSTTSDAFLQSK (15aa)
  •    Q16880    Asn-78
• NLGNNTK (7aa)
  •    Q16880    Asn-333
• DQPGHPVNR (9aa)
  •    Q64676    Asn-442
• DQPGHPVNR (9aa)
  •    Q16880    Asn-442

Taxonomy

• Mus musculus (House mouse)

Protein

• 2-hydroxyacylsphingosine 1-beta-galactosyltransferase / Mus musculus    Q64676

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:7 HexNAc:2 (avg mass : 1559.4021 )
• Hex:4 HexNAc:2 (avg mass : 1072.9749 )
• Hex:6 HexNAc:4 (avg mass : 1803.6497 )
• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )
• Hex:9 HexNAc:2 (avg mass : 1883.6869 )
• Hex:5 HexNAc:4 (avg mass : 1641.5073 )
• Hex:4 HexNAc:3 (avg mass : 1276.1699 )
• Hex:3 HexNAc:2 (avg mass : 910.8325 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• 2-hydroxyacylsphingosine 1-beta-galactosyltransferase / Mus musculus :
  •        Asn-442

Mass spectrometry validated peptide

• LSEIHKDQPGHPVNR (15aa)
  •    Q64676    Asn-442
• DQPGHPVNR (9aa)
  •    Q64676    Asn-442
• DQPGHPVNR (9aa)
  •    Q16880    Asn-442

Taxonomy

• Homo sapiens (Human)

Protein

• 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 / Homo sapiens    Q6PK18

Source

• Mammary Gland (UBERON_0001911)  

Reported structure

Composition

• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )

Disease

• Cancer, breast (DOID:1612)

Reference

• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed

Reported glycosite

• 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 / Homo sapiens :
  •        Asn-215
  •        Asn-267

Mass spectrometry validated peptide

• INSTEAR (7aa)
  •    Q6PK18    Asn-215
• INSTEAR (7aa)
  •    Q9D136    Asn-211
• FMFMEEGANK (10aa)
  •    Q6PK18    Asn-267

Taxonomy

• Mus musculus (House mouse)

Protein

• 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 / Mus musculus    Q9D136

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:6 HexNAc:2 (avg mass : 1397.2597 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 / Mus musculus :
  •        Asn-211

Mass spectrometry validated peptide

• INSTEAR (7aa)
  •    Q6PK18    Asn-215
• INSTEAR (7aa)
  •    Q9D136    Asn-211

Taxonomy

• Sus scrofa (Pig)

Protein

• 32 kDa enamelin / Sus scrofa    O97939

Source

• Enamel Organ (UBERON_0005176)  

Reported structure

• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / Gal(b1-3)GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc

Composition

• Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
• Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
• Hex:4 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2411.2187 )
• Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )

Disease

Reference

• Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed

Reported glycosite

• 32 kDa enamelin / Sus scrofa :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Trypanosoma cruzi

Protein

• 35/50 kDa surface glycoprotein / Trypanosoma cruzi

Source

• Cell Surface (GO_0009986)  

Reported structure

• O-Linked / No-core / Gal(b1-3)Gal(b1-6)[Galf(b1-4)]GlcNAc
• O-Linked / No-core / NeuAc(a2-3)Gal(b1-6)[Gal(b1-4)]GlcNAc
• O-Linked / No-core / Gal(b1-2)[Gal(b1-3)]Gal(b1-6)[Galf(b1-4)]GlcNAc
• O-Linked / No-core / Gal(b1-4)GlcNAc
• O-Linked / No-core / NeuAc(a2-3)Gal(b1-4)[Gal(b1-6)]GlcNAc
• O-Linked / No-core / Gal(b1-2)Gal(b1-6)[Gal(b1-4)]GlcNAc
• O-Linked / No-core / Galf(b1-4)[Gal(b1-6)]GlcNAc
• O-Linked / No-core / Gal(b1-4)ManNAc
• O-Linked / No-core / Gal(b1-4)[Gal(b1-6)]GlcNAc
• O-Linked / No-core / Gal(b1-2)[Gal(b1-3)]Gal(b1-6)[Gal(b1-2)Galf(b1-4)]GlcNAc
• O-Linked / No-core / Gal(b1-2)Gal(b1-2)Gal(b1-6)[Gal(b1-4)]GlcNAc
• O-Linked / No-core / Galf(b1-4)GlcNAc
• N-Linked/O-Linked / Truncated If N-Linked / GlcNAc
• O-Linked / No-core / Gal(b1-4)[Gal(b1-6)]ManNAc
• N-Linked / No-core / NeuAc(a2-3)Gal(b1-4)GlcNAc

Composition

• Hex:1 HexNAc:1 (avg mass : 383.3527 )
• Hex:2 HexNAc:1 (avg mass : 545.4951 )
• Hex:3 HexNAc:1 (avg mass : 707.6375 )
• HexNAc:1 (avg mass : 221.2103 )
• Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
• Hex:2 HexNAc:1 NeuAc:1 (avg mass : 836.753 )
• Hex:5 HexNAc:1 (avg mass : 1031.9223 )
• Hex:4 HexNAc:1 (avg mass : 869.7799 )

Disease

Reference

• Structure of O-glycosidically linked oligosaccharides from glycoproteins of Trypanosoma cruzi CL-Brener strain: evidence for the presence of O-linked sialyl-oligosaccharides. (2001 - Todeschini A, da Silveira E, Jones C, Wait R, Previato J, Mendona-Previato L) / Status : Reviewed
• The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. (1995 - Serrano A, Schenkman S, Yoshida N, Mehlert A, Richardson J, Ferguson M) / Status : Reviewed
• O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi. (1994 - Previato J, Jones C, Gonalves L, Wait R, Travassos L, Mendona-Previato L) / Status : Reviewed

Reported glycosite

• 35/50 kDa surface glycoprotein / Trypanosoma cruzi :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Homo sapiens (Human)

Protein

• 3-hydroxy-3-methylglutaryl-coenzyme A reductase / Homo sapiens    P04035

Source

• Mammary Gland (UBERON_0001911)  

Reported structure

Composition

• Hex:4 HexNAc:6 (avg mass : 1885.7549 )
• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:9 HexNAc:2 (avg mass : 1883.6869 )

Disease

• Cancer, breast (DOID:1612)

Reference

• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed

Reported glycosite

• 3-hydroxy-3-methylglutaryl-coenzyme A reductase / Homo sapiens :
  •        Asn-281

Mass spectrometry validated peptide

• WIADPSPQNSTADTSK (16aa)
  •    P04035    Asn-281

Taxonomy

• Trypanosoma cruzi

Protein

• 40/45 kDa glycoprotein / Trypanosoma cruzi

Source

• Cell Surface (GO_0009986)  

Reported structure

• O-Linked / No-core / Gal(b1-4)[Gal(b1-6)]GlcNAc
• O-Linked / No-core / Gal(b1-2)Gal(b1-6)[Gal(b1-3)]GlcNAc
• O-Linked / No-core / Gal(b1-3)GlcNAc
• O-Linked / No-core / Gal(b1-4)GlcNAc
• O-Linked / No-core / Gal(b1-2)Gal(b1-6)[Gal(b1-4)]GlcNAc
• O-Linked / No-core / Gal(b1-3)[Gal(b1-6)]GlcNAc

Composition

• Hex:1 HexNAc:1 (avg mass : 383.3527 )
• Hex:2 HexNAc:1 (avg mass : 545.4951 )
• Hex:3 HexNAc:1 (avg mass : 707.6375 )

Disease

Reference

• Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain. (1995 - Previato J, Jones C, Xavier M, Wait R, Travassos L, Parodi A, Mendona-Previato L) / Status : Reviewed

Reported glycosite

• 40/45 kDa glycoprotein / Trypanosoma cruzi :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Homo sapiens (Human)

Protein

• 4F2 cell-surface antigen heavy chain / Homo sapiens    P08195

Source

• Mammary Gland (UBERON_0001911)  
• Blood Serum (UBERON_0001977)  

Reported structure

Composition

• Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
• Hex:10 HexNAc:9 (avg mass : 3468.1943 )
• Hex:9 HexNAc:8 dHex:3
• Hex:7 HexNAc:4 dHex:1 NeuAc:2
• Hex:6 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2532.3085 )
• Hex:9 HexNAc:8 dHex:1 NeuAc:1
• Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
• Hex:6 HexNAc:5 dHex:3 NeuAc:1
• Hex:5 HexNAc:3 dHex:3
• Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
• Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
• Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
• Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
• Hex:8 HexNAc:7 NeuAc:1
• Hex:9 HexNAc:8 NeuAc:1
• Hex:7 HexNAc:6 dHex:5 (avg mass : 3102.8971 )
• Hex:7 HexNAc:6 NeuAc:1 (avg mass : 2663.44 )
• Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
• Hex:6 HexNAc:6 NeuAc:3 (avg mass : 3083.8134 )
• Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:9 HexNAc:2 (avg mass : 1883.6869 )
• Hex:4 HexNAc:3 dHex:3
• Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
• Hex:5 HexNAc:4 dHex:4
• Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
• Hex:6 HexNAc:4 NeuAc:2 (avg mass : 2386.1655 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
• Hex:9 HexNAc:8 dHex:1 (avg mass : 3248.9999 )
• Hex:8 HexNAc:7 (avg mass : 2737.5195 )
• Hex:12 HexNAc:2 (avg mass : 2370.1141 )
• Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
• Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
• Hex:6 HexNAc:3 dHex:3
• Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
• Hex:6 HexNAc:5 dHex:4 (avg mass : 2591.4167 )
• Hex:6 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 2037.8556 )
• Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
• Hex:7 HexNAc:6 dHex:2 (avg mass : 2664.4681 )
• Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
• Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
• Hex:6 HexNAc:3 dHex:2
• Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
• Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
• Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
• Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
• Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
• Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
• Hex:7 HexNAc:6 dHex:4
• Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
• Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
• Hex:7 HexNAc:6 dHex:5 NeuAc:4
• Hex:8 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 4048.6941 )
• Hex:10 HexNAc:9 dHex:1 (avg mass : 3614.3373 )

Disease

• Prostate cancer (DOID:10283)
• Cancer, breast (DOID:1612)

Reference

• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
• Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed

Reported glycosite

• 4F2 cell-surface antigen heavy chain / Homo sapiens :
  •        Asn-365
  •        Asn-381
  •        Asn-424

Mass spectrometry validated peptide

• DASSFIAEWQNITK (14aa)
  •    P08195    Asn-365
• DASSFLAEWQNITK (14aa)
  •    P08195    Asn-365
• DIENIKDASSFIAEWQNITK (20aa)
  •    P08195    Asn-365
• IIIAGTNSSDIQQIISIIESNK (22aa)
  •    P08195    Asn-381
• LLIAGTNSSDLQQILSLLESNK (22aa)
  •    P08195    Asn-381
• SIVTQYINATGNR (13aa)
  •    P08195    Asn-424
• SLVTQYLNATGNR (13aa)
  •    P08195    Asn-424

Taxonomy

• Mus musculus (House mouse)

Protein

• 4F2 cell-surface antigen heavy chain / Mus musculus    P10852

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:4 HexNAc:2 (avg mass : 1072.9749 )
• Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
• Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 2037.8556 )
• Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
• Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• 4F2 cell-surface antigen heavy chain / Mus musculus :
  •        Asn-166
  •        Asn-263
  •        Asn-385

Mass spectrometry validated peptide

• NQKDEINETDLK (12aa)
  •    P10852    Asn-166
• NLSEDR (6aa)
  •    P10852    Asn-263
• APLMPWNESSIFHIPR (16aa)
  •    P10852    Asn-385

Taxonomy

• Rattus norvegicus (Norway rat)

Protein

• 56 kDa intrinsic membrane protein / Rattus norvegicus

Source

• Cytoplasmic Vesicle (GO_0031410)  

Reported structure

• N-Linked/O-Linked / Truncated If N-Linked / GlcNAc

Composition

• HexNAc:1 (avg mass : 221.2103 )

Disease

Reference

• Intrinsic membrane glycoproteins with cytosol-oriented sugars in the endoplasmic reticulum. (1988 - Abeijon C, Hirschberg C) / Status : Reviewed

Reported glycosite

• 56 kDa intrinsic membrane protein / Rattus norvegicus :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Homo sapiens (Human)

Protein

• 5'-AMP-activated protein kinase catalytic subunit alpha-2 / Homo sapiens    P54646

Source

• Mammary Gland (UBERON_0001911)  
• Blood Serum (UBERON_0001977)  

Reported structure

Composition

• Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
• Hex:7 HexNAc:6 (avg mass : 2372.1821 )

Disease

• Cancer, breast (DOID:1612)

Reference

• Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed

Reported glycosite

• 5'-AMP-activated protein kinase catalytic subunit alpha-2 / Homo sapiens :
  •        Asn-388

Mass spectrometry validated peptide

• CPLDALNTTK (10aa)
  •    P54646    Asn-388

Taxonomy

• Mus musculus (House mouse)

Protein

• 5'-nucleotidase / Mus musculus    Q61503

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:5 HexNAc:2 (avg mass : 1235.1173 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• 5'-nucleotidase / Mus musculus :
  •        Asn-55
  •        Asn-313

Mass spectrometry validated peptide

• CLNASLCVGGVAR (13aa)
  •    Q61503    Asn-55
• VEFDDKGNVITSYGNPILLNSSIPEDATIK (30aa)
  •    Q61503    Asn-313

Taxonomy

• Torpedo californica (Pacific electric ray)

Protein

• Acetylcholine receptor protein / Torpedo californica    P02714    P02718    P02710    P02712

Source

• Electric Organ (UBERON_0006869)  

Reported structure

• N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
• N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Gal(b1-4)"
• N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-3)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x NeuAc"
• N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x NeuAc"
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Gal(b1-4) + NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x NeuAc"
• N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
• N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc"
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc

Composition

• Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
• Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
• Hex:4 HexNAc:5 NeuAc:1 (avg mass : 1973.8178 )
• Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )
• Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
• Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
• Hex:4 HexNAc:5 (avg mass : 1682.5599 )
• Hex:6 HexNAc:6 NeuAc:1 (avg mass : 2501.2976 )
• Hex:6 HexNAc:6 (avg mass : 2210.0397 )
• Hex:6 HexNAc:6 NeuAc:3 (avg mass : 3083.8134 )
• Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:9 HexNAc:2 (avg mass : 1883.6869 )
• Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
• Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
• Hex:3 HexNAc:6 (avg mass : 1723.6125 )
• Hex:4 HexNAc:6 (avg mass : 1885.7549 )
• Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
• Hex:4 HexNAc:6 NeuAc:1 (avg mass : 2177.0128 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
• Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
• Hex:5 HexNAc:4 (avg mass : 1641.5073 )
• Hex:5 HexNAc:5 NeuAc:2 (avg mass : 2427.2181 )
• Hex:4 HexNAc:4 (avg mass : 1479.3649 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
• Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
• Hex:5 HexNAc:6 NeuAc:1 (avg mass : 2339.1552 )
• Hex:3 HexNAc:4 (avg mass : 1317.2225 )
• Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
• Hex:5 HexNAc:6 (avg mass : 2047.8973 )

Disease

Reference

• Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed

Reported glycosite

• Acetylcholine receptor protein / Torpedo californica :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Bos taurus (Bovine)

Protein

• Acetylcholinesterase / Bos taurus    P23795

Source

• HEK293-EBNA (CVCL_6974)   Kidney (UBERON_0002113)  
• Kidney (UBERON_0002113)  
• Blood Serum (UBERON_0001977)  

Reported structure

• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)[GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-3)[Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ NeuAc(a2-?)"
• N-Linked / Hybrid / Man(?1-?)[Man(?1-?)]Man(a1-?)[GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / Gal(a1-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-3)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)Man(a1-3)[Gal(b1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
• N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ Gal(a1-?)"

Composition

• Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
• Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
• Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
• Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
• Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
• Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
• Hex:7 HexNAc:5 dHex:1 (avg mass : 2315.1301 )
• Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
• Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
• Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
• Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
• Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
• Hex:4 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2411.2187 )
• Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
• Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
• Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
• Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
• Hex:6 HexNAc:5 NeuAc:4 (avg mass : 3171.8763 )
• Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )

Disease

Reference

• Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed

Reported glycosite

• Acetylcholinesterase / Bos taurus :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Mus musculus (House mouse)

Protein

• Acetylcholinesterase / Mus musculus    P21836

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• Acetylcholinesterase / Mus musculus :
  •        Asn-296

Mass spectrometry validated peptide

• LVGCPPGGAGGNDTELIACLR (21aa)
  •    P21836    Asn-296

Taxonomy

• Homo sapiens (Human)

Protein

• Acid ceramidase / Homo sapiens    Q13510

Source

• Mammary Gland (UBERON_0001911)  

Reported structure

Composition

• Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
• Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
• Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
• Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )
• Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
• Hex:6 HexNAc:3 dHex:2
• Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
• Hex:4 HexNAc:2 dHex:1 (avg mass : 1219.1179 )
• Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
• Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
• Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
• Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
• Hex:7 HexNAc:2 (avg mass : 1559.4021 )
• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
• Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
• Hex:4 HexNAc:3 dHex:3
• Hex:9 HexNAc:2 (avg mass : 1883.6869 )
• Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
• Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
• Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
• Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
• Hex:3 HexNAc:2 (avg mass : 910.8325 )

Disease

• Cancer, breast (DOID:1612)

Reference

• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed

Reported glycosite

• Acid ceramidase / Homo sapiens :
  •        Asn-259
  •        Asn-286
  •        Asn-342
  •        Asn-348

Mass spectrometry validated peptide

• TVIENSTSYEEAK (13aa)
  •    Q13510    Asn-259
• TVLENSTSY (9aa)
  •    Q13510    Asn-259
• IIAPAYFIIGGNQSGEGCVITR (22aa)
  •    Q13510    Asn-286
• GGNQSGEGCVITR (13aa)
  •    Q13510    Asn-286
• ILAPAYFILGGNQSGEG (17aa)
  •    Q13510    Asn-286
• ILGGNQSGEGCVITR (15aa)
  •    Q13510    Asn-286
• TSQENISFETMYDVISTKPVINK (23aa)
  •    Q13510    Asn-348

Taxonomy

• Mus musculus (House mouse)

Protein

• Acid ceramidase / Mus musculus    Q9WV54

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:2 HexNAc:2 (avg mass : 748.6901 )
• Hex:7 HexNAc:2 (avg mass : 1559.4021 )
• Hex:4 HexNAc:2 (avg mass : 1072.9749 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )
• Hex:6 HexNAc:2 Ph:1 (avg mass : 1477.2396 )
• Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
• Hex:3 HexNAc:2 (avg mass : 910.8325 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• Acid ceramidase / Mus musculus :
  •        Asn-258
  •        Asn-341
  •        Asn-347

Mass spectrometry validated peptide

• SVLENTTSYEEAK (13aa)
  •    Q9WV54    Asn-258
• CLNHTTQK (8aa)
  •    Q9WV54    Asn-341
• NLSFATIYDVLSTKPVLNK (19aa)
  •    Q9WV54    Asn-347
• CLNHTTQKNLSFATIYDVLSTKPVLNK (27aa)
  •    Q9WV54    Asn-347

Taxonomy

• Leishmania mexicana

Protein

• Acid phosphatase (sap) / Leishmania mexicana    Q25336

Source

• Secretion of Exocrine Gland (UBERON_0000456)  

Reported structure

• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-P)
• O-Linked / No-core / Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-P-6)Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-P-6)Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)[Glc(b1-3)]Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Glc(b1-3)[Man(a1-P-6)]Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)
• O-Linked / No-core / Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-2)Man(a1-P-6)Gal(b1-4)Man(a1-P-6)Gal(b1-4)Man(a1-P)

Composition

• Hex:1 Ph:1 (avg mass : 260.1376 )
• Hex:8 Ph:3 (avg mass : 1555.0942 )
• Hex:12 Ph:3 (avg mass : 2203.6638 )
• Hex:6 Ph:3 (avg mass : 1230.8094 )
• Hex:5 Ph:3 (avg mass : 1068.667 )
• Hex:7 Ph:3 (avg mass : 1392.9518 )
• Hex:10 Ph:3 (avg mass : 1879.379 )
• Hex:2 Ph:1 (avg mass : 422.28 )
• Hex:11 Ph:3 (avg mass : 2041.5214 )
• Hex:3 Ph:1 (avg mass : 584.4224 )
• Hex:6 Ph:1 (avg mass : 1070.8496 )
• Hex:4 Ph:1 (avg mass : 746.5648 )
• Hex:9 Ph:3 (avg mass : 1717.2366 )
• Hex:5 Ph:1 (avg mass : 908.7072 )

Disease

Reference

• O- and N-glycosylation of the Leishmania mexicana-secreted acid phosphatase. Characterization of a new class of phosphoserine-linked glycans. (1994 - Ilg T, Overath P, Ferguson M, Rutherford T, Campbell D, McConville M) / Status : Reviewed

Reported glycosite

• Acid phosphatase (sap) / Leishmania mexicana :
  •        Undefined site

Mass spectrometry validated peptide

Taxonomy

• Mus musculus (House mouse)

Protein

• Acid-sensing ion channel 4 / Mus musculus    Q7TNS7

Source

• Brain (UBERON_0000955)  

Reported structure

Composition

• Hex:8 HexNAc:2 (avg mass : 1721.5445 )
• Hex:5 HexNAc:2 (avg mass : 1235.1173 )
• Hex:6 HexNAc:2 (avg mass : 1397.2597 )

Disease

Reference

• Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed

Reported glycosite

• Acid-sensing ion channel 4 / Mus musculus :
  •        Asn-138
  •        Asn-243

Mass spectrometry validated peptide

• HSALSDADIFHLANLTGLPPKDR (23aa)
  •    Q7TNS7    Asn-138
• ETNETSFEAGIR (12aa)
  •    Q7TNS7    Asn-243